Condensed Consolidated Statements of Cash Flow (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011 Restated [Member]
Cash flows from operating activities
Net loss	$ (33,465)	$ (5,367)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	9,843	10,765
Deferred income taxes	(3,809)	(5,671)
Unrealized foreign exchange gains	(20,196)	(50,940)
Stock options fair value expense	1,589	1,336
Equity loss in affiliates	0	7,946
Gain on fair value remeasurement of previously held equity interest	0	(6,397)
Other non cash items	1,042	2,794
Changes in operating assets and liabilities:
Accounts receivable	201,151	274,861
Inventories	(19,190)	(17,033)
Prepaid expenses and other current assets	(6,686)	(13,868)
Trade accounts payable	(69,031)	(59,551)
Other accrued liabilities and payables (including taxes)	(52,929)	(95,541)
Net cash provided by operating activities	8,319	43,334
Cash flows from investing activities
Purchase of fixed assets	(4,781)	(3,169)
Proceeds from the disposal of fixed assets	234	0
Purchase of intangibles	0	(693)
Purchase of trademarks	0	(17,473)
Acquisitions of subsidiaries, net of cash acquired	0	(24,124)
Net cash used in investing activities	(4,547)	(45,459)
Cash flows from financing activities
Borrowings on bank loans and overdraft facility	14,987	30,983
Debt security, net of debt issuance cost of $838	69,162	0
Repayment of Convertible Senior Notes	(35,532)	0
Payment of bank loans, overdraft facility and other borrowings	(37,214)	(34,401)
Issuance of shares in private placement	30,000	0
Decrease in short term capital leases payable	(10)	(277)
Proceeds from options exercised	0	72
Net cash provided by / (used in) financing activities	41,393	(3,623)
Currency effect on brought forward cash balances	(895)	10,166
Net increase in cash	44,270	4,418
Cash and cash equivalents at beginning of period	94,410	122,116
Cash and cash equivalents at end of period	138,680	126,534
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries	$ 0	$ 23,175